Biomarker diagnostics developer Singulex has added Andrew Marion to its board of directors, the company said last week.
 
Marion is the founder of Applied Biosystems. He is currently a director at Molecular Devices, Applied Imaging, Alpha M.O.S., and Guava Technologies.
 
He was CEO at ABI for seven years and was chairman of the board for six, after which he served as vice president at PerkinElmer.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.